Literature DB >> 25433164

Variability of permeability estimation from different protocols of subculture and transport experiments in cell monolayers.

Davinia Oltra-Noguera1, Victor Mangas-Sanjuan2, Amparo Centelles-Sangüesa1, Ignacio Gonzalez-Garcia2, Gloria Sanchez-Castaño1, Marta Gonzalez-Alvarez3, Vicente-German Casabo1, Virginia Merino1, Isabel Gonzalez-Alvarez3, Marival Bermejo4.   

Abstract

INTRODUCTION: In vitro models with high predictive ability have been revealed as strong tools for pharmaceutical industry. However, the variability in permeability estimations complicates the comparison and combination of data from different laboratories and it makes necessary the careful validation of the model and the continuous suitability demonstration. The adequate standardization of pre-experimental, experimental and post-experimental factors might help to reduce the inter- and intra-laboratory variability in permeability values.
METHODS: The objective of this paper is the evaluation of the effect of passage number, experimental protocol, time after seeding and calculation method on the permeability values and their variability in transport experiments in Caco-2, MDCK and MDCK-MDR1 cells. Metoprolol, Lucifer yellow and Rhodamine-123 were used to check the performance of the cell lines. Protocols used differ mainly in the differentiation time and the filter support coating with collagen. Data was analyzed with sink and non-sink approaches. The final purpose was to explore pre-experimental, experimental and post-experimental conditions in order to select the best experimental scenarios for permeability assays.
RESULTS: Results indicated that for passive diffusion studies, coating helps cell differentiation in a more stable manner in all cell lines compared to protocol without coating which showed permeability changes with passages and more variable values. In both protocols the paracellular route became more restricted with higher passage numbers. Functionality of P-gp assessed with Rhodamine permeability did not change with passage number in Caco-2 cells with any of the protocols but increased in both protocols in MDCK and MDCK-MDR1 cells. Protocol without coating showed the less variable results in these cell lines. Rhodamine permeabilities increased with higher maturation times due to a higher expression of the transporter. Nevertheless for compounds absorbed by passive diffusion there was not a clear trend neither in permeability values nor in variability. DISCUSSION: As a conclusion, we have confirmed the influence of maturation conditions and passage number in permeability values and in their variability. Based on our results protocol with coating would be more adequate for studies of compounds absorbed by passive diffusion but the protocol without coating gave us better results for studies about P-gp interactions.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Caco-2; Cell monolayer; Culture standardization; MDCK; Permeability; Variability

Mesh:

Year:  2014        PMID: 25433164     DOI: 10.1016/j.vascn.2014.11.004

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  8 in total

1.  Exploring different strategies for imbalanced ADME data problem: case study on Caco-2 permeability modeling.

Authors:  Hai Pham-The; Gerardo Casañola-Martin; Teresa Garrigues; Marival Bermejo; Isabel González-Álvarez; Nam Nguyen-Hai; Miguel Ángel Cabrera-Pérez; Huong Le-Thi-Thu
Journal:  Mol Divers       Date:  2015-12-07       Impact factor: 2.943

2.  Toxicologic/transport properties of NCS-382, a γ-hydroxybutyrate (GHB) receptor ligand, in neuronal and epithelial cells: Therapeutic implications for SSADH deficiency, a GABA metabolic disorder.

Authors:  K R Vogel; G R Ainslie; A McConnell; J-B Roullet; K M Gibson
Journal:  Toxicol In Vitro       Date:  2017-10-12       Impact factor: 3.500

Review 3.  The Contributions of Human Mini-Intestines to the Study of Intestinal Physiology and Pathophysiology.

Authors:  Huimin Yu; Nesrin M Hasan; Julie G In; Mary K Estes; Olga Kovbasnjuk; Nicholas C Zachos; Mark Donowitz
Journal:  Annu Rev Physiol       Date:  2017-02-10       Impact factor: 22.163

4.  Characterization of preclinical in vitro and in vivo pharmacokinetics properties for KBP-7018, a new tyrosine kinase inhibitor candidate for treatment of idiopathic pulmonary fibrosis.

Authors:  Zhenhua Huang; Heran Li; Qian Zhang; Xiaojuan Tan; Fangzheng Lu; Hongzhuo Liu; Sanming Li
Journal:  Drug Des Devel Ther       Date:  2015-08-05       Impact factor: 4.162

5.  Cyclometalated Iminophosphorane Gold(III) and Platinum(II) Complexes. A Highly Permeable Cationic Platinum(II) Compound with Promising Anticancer Properties.

Authors:  Malgorzata Frik; Jacob Fernández-Gallardo; Oscar Gonzalo; Víctor Mangas-Sanjuan; Marta González-Alvarez; Alfonso Serrano del Valle; Chunhua Hu; Isabel González-Alvarez; Marival Bermejo; Isabel Marzo; María Contel
Journal:  J Med Chem       Date:  2015-07-22       Impact factor: 7.446

6.  Improvement in Solubility-Permeability Interplay of Psoralens from Brosimum gaudichaudii Plant Extract upon Complexation with Hydroxypropyl-β-cyclodextrin.

Authors:  Rúbia Darc Machado; Júlio C G Silva; Luís A D Silva; Gerlon de A R Oliveira; Luciano M Lião; Eliana M Lima; Mariana C de Morais; Edemilson C da Conceição; Kênnia R Rezende
Journal:  Molecules       Date:  2022-07-19       Impact factor: 4.927

7.  Congeners-Specific Intestinal Absorption Of Microcystins In An In Vitro 3D Human Intestinal Epithelium: The Role Of Influx/Efflux Transporters.

Authors:  Laura Turco; Nicoletta Santori; Franca M Buratti; Jean-Lou C M Dorne; Emanuela Testai
Journal:  Front Toxicol       Date:  2022-08-05

8.  Investigation to Explain Bioequivalence Failure in Pravastatin Immediate-Release Products.

Authors:  Alejandro Ruiz-Picazo; Sarin Colón-Useche; Blanca Perez-Amorós; Marta González-Álvarez; Irene Molina-Martínez; Isabel González-Álvarez; Alfredo García-Arieta; Marival Bermejo
Journal:  Pharmaceutics       Date:  2019-12-09       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.